(Q37393182)

English

Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study

scientific article published on June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eric Boerwinkle

2

object named as

Eric Boerwinkle

0 references

7

object named as

Donna K Arnett

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3

0 references

John Wiegand Eckfeldt

5

object named as

John H Eckfeldt

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Catherine Leiendecker-Foster

6

object named as

Catherine Leiendecker-Foster

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Amy I Lynch

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Charles E Ford

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

1 June 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Pharmacogenetics and Genomics

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

415-421

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Pharmacogenetics of antihypertensive treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Characterization of the 5'-flanking region for the human fibrinogen beta gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

26 June 2018

Plasma lipids and blood viscosity in patients with cerebrovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

[The relationship between the five beta-fibrinogen gene polymorphisms and cerebral infarction].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Effect of various antihypertensive drugs on plasma fibrinogen levels in patients with essential hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

3 December 2018

Common Genetic Variation in Five Thrombosis Genes and Relations to Plasma Hemostatic Protein Level and Cardiovascular Disease Risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

3 December 2018

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Identification of beta-FBG-455G/A polymorphisms in 210 samples of Guangdong population and the relationship with plasma fibrinogen level]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effect of beta-Fibrinogen-455 Gene Polymorphism on Plasma Fibrinogen Levels in Patients with Ischemic Stroke]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrin clot structure in patients with end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/FPC.0B013E32832A8E81

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37393182&oldid=1741957202"